U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Acquired by Chatham Capital Group Inc.

Chatham Capital Group Inc. increased its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPHFree Report) by 14.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,400 shares of the company’s stock after purchasing an additional 2,450 shares during the quarter. Chatham Capital Group Inc.’s holdings in U.S. Physical Therapy were worth $2,190,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Northwest Bank & Trust Co purchased a new stake in shares of U.S. Physical Therapy during the 4th quarter worth about $37,000. SRS Capital Advisors Inc. grew its stake in U.S. Physical Therapy by 308.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock worth $38,000 after buying an additional 308 shares during the last quarter. Principal Securities Inc. bought a new position in U.S. Physical Therapy during the 4th quarter worth $100,000. Benjamin Edwards Inc. grew its stake in shares of U.S. Physical Therapy by 17.4% in the fourth quarter. Benjamin Edwards Inc. now owns 1,692 shares of the company’s stock worth $158,000 after purchasing an additional 251 shares in the last quarter. Finally, Thoroughbred Financial Services LLC bought a new position in shares of U.S. Physical Therapy in the fourth quarter worth $223,000.

U.S. Physical Therapy Stock Performance

NYSE:USPH traded down $0.70 during mid-day trading on Friday, hitting $92.42. 318,260 shares of the company’s stock traded hands, compared to its average volume of 116,619. The firm has a 50 day moving average of $100.29 and a two-hundred day moving average of $99.84. U.S. Physical Therapy, Inc. has a 12 month low of $78.08 and a 12 month high of $124.11. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of 75.14, a price-to-earnings-growth ratio of 3.59 and a beta of 1.40. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07). U.S. Physical Therapy had a return on equity of 8.03% and a net margin of 4.72%. The firm had revenue of $155.70 million during the quarter, compared to the consensus estimate of $153.30 million. During the same quarter in the prior year, the business posted $0.59 EPS. U.S. Physical Therapy’s revenue was up 4.8% compared to the same quarter last year. On average, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.84 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Thursday, May 23rd were given a dividend of $0.44 per share. The ex-dividend date of this dividend was Wednesday, May 22nd. This represents a $1.76 annualized dividend and a dividend yield of 1.90%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 143.09%.

Insider Buying and Selling

In related news, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $107.57, for a total transaction of $268,925.00. Following the completion of the sale, the director now directly owns 3,280 shares of the company’s stock, valued at approximately $352,829.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $107.57, for a total transaction of $268,925.00. Following the completion of the sale, the director now directly owns 3,280 shares of the company’s stock, valued at approximately $352,829.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $105.46, for a total value of $181,813.04. Following the sale, the chief operating officer now directly owns 6,970 shares of the company’s stock, valued at $735,056.20. The disclosure for this sale can be found here. Insiders sold 10,724 shares of company stock worth $1,114,385 in the last 90 days. 1.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on USPH shares. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a report on Wednesday, March 13th. Barrington Research reissued an “outperform” rating and issued a $122.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, May 9th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus target price of $125.67.

Read Our Latest Stock Analysis on U.S. Physical Therapy

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHFree Report).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.